Use of lymph node ratio to guide clinical decision-making concerning adjuvant radiotherapy in pT1-2N1 rectal cancer-Reference-Cited by-同舟云学术

Use of lymph node ratio to guide clinical decision-making concerning adjuvant radiotherapy in pT1-2N1 rectal cancer

Published:2023-05-06 Issue:1 Volume:38 Page:
ISSN:1432-1262
Container-title:International Journal of Colorectal Disease
language:en
Short-container-title:Int J Colorectal Dis

Author:

Luo Dakui,Ye Zilan,Zhang Ruijia,Li Qingguo,Li Xinxiang

Funder

National Natural Science Foundation of China

Shanghai Municipal Natural Science Foundation

Shanghai Medical Innovation Research Project

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

https://link.springer.com/content/pdf/10.1007/s00384-023-04415-8.pdf

Reference19 articles.

1. Gunderson LL et al (2008) Stratification of rectal cancer stage for selection of postoperative chemoradiotherapy: current status. Gastrointest Cancer Res 2(1):25–33

2. Schrag D et al (2014) Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial. J Clin Oncol 32(6):513–518

3. Gunderson LL et al (2004) Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol 22(10):1785–1796

4. Huh JW, Kim YJ, Kim HR (2010) Ratio of metastatic to resected lymph nodes as a prognostic factor in node-positive colorectal cancer. Ann Surg Oncol 17(10):2640–2646

5. Prassas D et al (2021) Prognostic discrimination of alternative lymph node classification systems for patients with radically resected non-metastatic colorectal cancer: a cohort study from a single tertiary referral center. Cancers (Basel) 13(15)

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic performance of Node-RADS score for mesorectal lymph node metastasis in rectal cancer;Abdominal Radiology;2024-07-24